Skip to main content
. 2024 Mar 21;15(2):287–297. doi: 10.14740/wjon1800

Table 1. Clinical Characteristic of UTUC Patients Receiving RNU.

Variables Number of patients (%) (n = 217) Median (Q1 - Q3)
Age 71 (63 - 76)
Gender
  Male 98 (45.16)
  Female 119 (54.84)
BMI 24.3 (21.92 - 26.93)
CCI 5 (4 - 6)
Smoking
  Yes 37 (17.05)
  No 180 (82.95)
DM
  Yes 83 (38.25)
  No 134 (61.75)
Hypertension
  Yes 177 (81.57)
  No 40 (18.43)
Grade
  Low 25 (11.52)
  High 192 (88.48)
T stage
  Tis/Ta/T1 106 (48.85)
  T2/T3/T4 111 (51.15)
Nodal status
  N0/Nx 207 (95.39)
  N1/N2 10 (4.61)
Initial metastasis
  Yes 5 (2.3)
  No 212 (97.7)
Multifocality
  Yes 34 (15.67)
  No 183 (84.33)
Size
  < 3cm 97 (44.7)
  ≥ 3cm 120 (55.3)
Squamous differentiation
  Yes 5 (2.3)
  No 212 (97.7)
Free resection margin
  Yes 208 (95.85)
  No 9 (4.15)
Adjuvant therapy
  Yes 44 (20.28)
  No 173 (79.72)
CHOL 170 (144 - 193)
  < 200 177 (81.57)
  ≥ 200 40 (18.43)
HDL 43.8 (35.7 - 56.4)
  < 40 (men), < 50 (female) 107 (49.31)
  ≥ 40 (men), ≥ 50 (female) 110 (50.69)
LDL 93.6 (75.3 - 114)
  < 130 185 (85.25)
  ≥ 130 32 (14.75)
TG 103 (78 - 150)
  < 150 162 (74.65)
  ≥ 150 55 (25.35)

RNU: radical nephroureterectomy; UTUC: upper tract urothelial carcinoma; BMI: body mass index; CCI: Charlson Comorbidity Index; DM: diabetes mellitus; CHOL: cholesterol; HDL: high-density lipoprotein; LDL: low-density lipoprotein; TG: triacylglycerol.